Zymeworks Inc., a biotechnology company, develops biotherapeutics for the treatment of cancer, inflammation, and autoimmune diseases. The company's platforms include Azymetric multispecific antibody platform; Drug Conjugate platform that includes a suite of proprietary cytotoxins comprising...
51 insider purchases on record · latest filing 2025-05-19.
Insiders have also filed 69 sale transactions at ZYME.